NCT04718532

Unknown

A New Technique For Retinal Disease Treatment

Second Affiliated Hospital, Zhejiang University, School of Medicine Source

Compare

Other study identifiers

Sponsor study identifier

研2019-428

Study Type

observational

Estimated enrollment

2,000

Locations

1 country

Sites

1

Timeline

Study Start

January 1, 2016

Actual (reported)

Primary Completion

January 1, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

December 31, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

With the advent of the era of precision medicine, based on FFA image deep learning to identify the area of fundus lesions, registration of fundus images, according to the severity of fundus diseases to design the optimal laser energy and path, the accurate treatment of fundus diseases has urgent clinical needs and very important significance

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 2,000 participants
Study completion date: December 31, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 1, 2016
Actual (reported)
First Submitted
January 18, 2021
Actual (reported)
First Posted
January 22, 2021
Actual (reported)
Primary Completion
January 1, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2023
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: January 22, 2021
Status Verified: January 2021
Last Update Submitted: January 18, 2021

Conditions

Retina Disorder

Outcome Measures

Primary Outcomes (1)

artificial intelligence
using data to develop deep learning models
2016.01-2023.12

Study Arms (1)

patients

patients with retinal diseases

Eligibility Criteria

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

patients undergo retinal exmination at eye center in the Second Affiliated Hospital of Zhejiang University

You may qualify if:

patients with retinal diseases

You may not qualify if:

Sponsors & Collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicine
Otherlead

Study Sites (1)

The Second Affiliated Hospital of Zhejiang University

Hanzhou, Zhejiang, China

RECRUITING

Jin Kai, MDCONTACT13646828461

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

Jin Kai, MD
Zhejiang University
PRINCIPAL INVESTIGATOR
Xu Yufeng, MD
Zhejiang University
PRINCIPAL INVESTIGATOR
Lou Lixia, MD
Zhejiang University
PRINCIPAL INVESTIGATOR

Central Study Contacts

Jin Kai, MD

CONTACT

13646828461 jinkai@zju.edu.cn

Study Design

Study Type: observational
Observational Model: CASE CROSSOVER
Time Perspective: CROSS SECTIONAL
Target Duration: 4 Years
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

January 18, 2021

First Posted

January 22, 2021

Study Start

January 1, 2016

Actual (reported)

Primary Completion

January 1, 2023

Estimated (date passed)

NCT05229094

EVA Nexus Vitrectomy Device Field Observation Study

Completed

NCT07082855

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Phase 3Not Yet Recruiting

NCT07495319

Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population

Not ApplicableCompleted

patients with other disease affect retinal exmination

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

December 31, 2023

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

January 22, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04718532
Data provider: ClinicalTrials.gov
Source updated: 2021-01-22
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:19 UTC

Locations

CN(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

patients

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Data Sharing

Source record

Locations